Relay Therapeutics (RLAY) News Today $3.22 -0.27 (-7.74%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.45 +0.23 (+7.14%) As of 08/8/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RLAY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Relay (RLAY) Q2 Loss Narrows 41%August 7 at 6:06 PM | fool.comRelay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 7 at 4:18 PM | globenewswire.comRelay Therapeutics Q2 2025 Earnings PreviewAugust 7 at 6:42 AM | seekingalpha.comPreview: Relay Therapeutics's EarningsAugust 7 at 6:42 AM | benzinga.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 8.2% - Here's What HappenedAugust 5, 2025 | marketbeat.comBarclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PTAugust 5, 2025 | msn.comRelay Therapeutics: What's Next For H2 2025?August 2, 2025 | seekingalpha.comBrokerages Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Target Price at $17.67August 2, 2025 | americanbankingnews.comBarclays Reiterates a Buy Rating on Relay Therapeutics (RLAY)August 1, 2025 | msn.comInsider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells 4,069 Shares of StockJuly 31, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Insider Peter Rahmer Sells 15,724 SharesJuly 31, 2025 | marketbeat.comInsider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells 18,276 Shares of StockJuly 31, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) CFO Thomas Catinazzo Sells 18,380 SharesJuly 31, 2025 | marketbeat.comDonald A. Bergstrom Sells 26,701 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) StockJuly 31, 2025 | marketbeat.comRelay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025July 31, 2025 | globenewswire.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells $15,218.06 in StockJuly 31, 2025 | insidertrades.comRelay Therapeutics (RLAY) to Release Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comRelay Therapeutics has positive read from Celcuity data, says BarclaysJuly 30, 2025 | finance.yahoo.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 30, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Sees Large Volume Increase - Still a Buy?July 25, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 5.6% - Should You Buy?July 16, 2025 | marketbeat.comPrivate Capital Advisors Inc. Acquires Shares of 100,000 Relay Therapeutics, Inc. (NASDAQ:RLAY)July 14, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sanjiv Patel Sells 61,379 SharesJuly 11, 2025 | insidertrades.comSanjiv Patel Sells 61,379 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) StockJuly 10, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 5, 2025 | marketbeat.comRelay Therapeutics, Inc. (RLAY) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comBofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PTJune 24, 2025 | insidermonkey.comRelay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.9% - Time to Sell?June 20, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Stock Price Up 5.7% - Here's What HappenedJune 18, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Shares Gap Down - Here's What HappenedJune 13, 2025 | marketbeat.comRelay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of DirectorsJune 11, 2025 | globenewswire.comRelay Therapeutics (NASDAQ:RLAY) Trading 6.7% Higher - What's Next?June 10, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 10, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Sees Large Growth in Short InterestJune 5, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Bank of America Corp DEJune 4, 2025 | marketbeat.comSquarepoint Ops LLC Increases Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY)June 3, 2025 | marketbeat.comNuveen Asset Management LLC Increases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)June 3, 2025 | marketbeat.comJane Street Group LLC Cuts Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)June 3, 2025 | marketbeat.comRelay Therapeutics’ RLY-2608 Shows Promising 11-Month PFS in Breast CancerJune 2, 2025 | msn.comRelay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025June 2, 2025 | globenewswire.comTwo Sigma Investments LP Sells 199,482 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)May 31, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 5.1% - Here's What HappenedMay 30, 2025 | marketbeat.comRelay Therapeutics to Participate in Two Upcoming Investor Conferences in JuneMay 29, 2025 | globenewswire.comRelay Therapeutics’ SWOT analysis: ai-driven biotech stock faces pivotal yearMay 29, 2025 | investing.comVoloridge Investment Management LLC Cuts Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)May 29, 2025 | marketbeat.comMan Group plc Buys Shares of 173,605 Relay Therapeutics, Inc. (NASDAQ:RLAY)May 27, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Shares Purchased by Millennium Management LLCMay 26, 2025 | marketbeat.comNorthern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)May 24, 2025 | marketbeat.comBNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)May 22, 2025 | marketbeat.com Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Email Address RLAY Media Mentions By Week RLAY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLAY News Sentiment▼0.200.38▲Average Medical News Sentiment RLAY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLAY Articles This Week▼95▲RLAY Articles Average Week Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMRX News NAMS News KNSA News RXRX News ARWR News IDYA News CNTA News BHC News IBRX News AGIO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RLAY) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
